0002007317-24-000057.txt : 20240202
0002007317-24-000057.hdr.sgml : 20240202
20240202161332
ACCESSION NUMBER: 0002007317-24-000057
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 24591559
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neumann Mark
CENTRAL INDEX KEY: 0001756211
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O INTRA-CELLULAR THERAPIES, INC.
STREET 2: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
144
1
primary_doc.xml
144
0001756211
XXXXXXXX
LIVE
0001567514
Intra-Cellular Therapies, Inc.
001-36274
430 EAST 29TH STREET
NEW YORK
NY
10016
212-923-3344
Neumann Mark
Officer
Common
Merrill Lynch
75 Rockefeller Plaza
New York
NY
10019
11860
795670.96
96238126
02/02/2024
NASDAQ
common
02/23/2021
compensation
Mark Neumann
N
11860
02/02/2024
compensation
N
Mark Neumann
430 EAST 29TH STREET
NEW YORK
NY
10016
common
11/06/2023
26754
1496117.34
02/02/2024
03/14/2023
Mark Neumann